a provider of therapeutic antibodies for inflammation and immuno-oncology
Industry Biotechnology
A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with HRMY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then HRMY could also see price increases.
Ticker / NAME | Correlation To ANAB | 1D Price Change % | ||
---|---|---|---|---|
ANAB | 100% | -3.49% | ||
HRMY - ANAB | 42% Loosely correlated | -3.53% | ||
CRMD - ANAB | 39% Loosely correlated | -2.74% | ||
SAGE - ANAB | 38% Loosely correlated | N/A | ||
PGEN - ANAB | 36% Loosely correlated | -3.57% | ||
ABSI - ANAB | 35% Loosely correlated | -13.74% | ||
More |
Ticker / NAME | Correlation To ANAB | 1D Price Change % |
---|---|---|
ANAB | 100% | -3.49% |
immuno-oncology theme (4 stocks) | 88% Closely correlated | -3.68% |
drugs theme (254 stocks) | 40% Loosely correlated | -1.72% |
cancer theme (82 stocks) | 40% Loosely correlated | -2.38% |
therapeutics theme (53 stocks) | 38% Loosely correlated | -2.44% |
fighting cancer theme (12 stocks) | 35% Loosely correlated | -2.28% |
More |